AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Palo Alto Networks CEO: “We’re happy Wiz is now part of Google, it gives us more room to operate”
2
“Younger people are getting cancer more and more. We have to make kinder medicines.”
3
The $2.3 billion mystery arms deal Israel won’t explain
4
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
5
Navan shares extend decline as losses widen and CFO plans exit
More news

Nasdaq

20 stories about Nasdaq
אורי הדומי מנכ"ל מזור רובוטיקה

Acquisition by Medtronic Complete, Mazor Delists

20.12.18|Lilach Baumer
Medtronic paid $1.3 billion in cash for the Israeli surgical robotics company. Including Medtronic’s existing stake, the deal is valued at $1.7 billion
רמון לגוארטה מנכל פפסיקו דניאל בירנבאום מנכל סודה סטרים מסיבת עיתונאים רכישת סודה סטרים

PepsiCo Completes SodaStream Acquisition

05.12.18|CTech
SodaStream will delist from the Tel Aviv Exchange at Wednesday market close
נאסדק

$10 Million Public Offering Sends Interception Firm’s Stock Plummeting

26.11.18|CTech
Tel Aviv-based Ability Inc. dropped around 46% by Friday market close following its announcement
נאסדק

Electronics 3D Printer Company Nano Dimension Wants to Raise $29 Million on Nasdaq

22.11.18|Lilach Baumer
The Tel Aviv and Nasdaq-listed company submitted a public offering prospectus to the SEC Wednesday
רונן סמואל מנכ"ל חברת קורנית

Under New Management, Printer Maker Kornit Reports 32% Increase in Quarterly Revenues

14.11.18|Dror Reich
In August, HP veteran Ronen Samuel replaced Kornit’s former CEO for the past four years, Gabi Seligsohn
מנכ"ל טאואר ראסל אלוונגר

Tower Semiconductor's Stock Down 21% Following Underwhelming Third Quarter Results

30.10.18|CTech
Tower reported revenues of $323 million for the quarter ending Sept. 30, down 9% compared with the same period last year, and 3.5% short of prior estimates
נאסדק

Gamida Cell Downprices Shares to Raise $50 Million Nasdaq IPO

28.10.18|Lilach Baumer
The Israel-based biotech company offered its shares at $8, below its previous intention of $13 to $15 per share
אייל ולדמן מלאנוקס

Mellanox Considers Sale, Says CNBC Report

26.10.18|Lilach Baumer
Mellanox published its preliminary third-quarter results for 2018, reporting its fifth consecutive quarter of record results
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases
קולפלנט דיו ביולוגי

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
נאסד"ק וול סטריט

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
נאסד"ק וול סטריט

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich
The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution
default image

Nasdaq-Listed Diabetes Monitoring Company Dario Raises $10.3 Million in Private Placement

16.09.18|CTech
Israel-headquartered Dario develops a diabetes monitoring device that lets users test and track their blood-glucose levels using a smartphone
נאסדק נאסד"ק ניו יורק בורסה בועה

Barclays Sees Potential Upside in Nice Stock Following Second-Quarter Reports

13.08.18|CTech
On Thursday, Israel-headquartered Nice reported GAAP revenues of $342 million, a 10% increase year-over-year, bolstered by a 28% year-over-year increase in cloud revenues
נאסד"ק וול סטריט

RedHill’s Clinical Trial Results Undermine Its Underwritten Offering

12.08.18|Dror Reich
The gastro treatment company announced a successful Crohn's disease treatment trial two weeks ago. While investors initially seemed hyped, successful trials from competitors brought RedHill’s stock down since
פאנל סולארי אנרגיה מתחדשת

SolarEdge Extends Patents Lawsuit Against Huawei

01.08.18|Amarelle Wenkert
The solar energy company has a pending lawsuit in Germany against the Chinese telecommunications company and a German distributor
תרופות כדורים

Gastro Treatment Company RedHill Jumps on Nasdaq Following Successful Clinical Trial

30.07.18|Lilach Baumer
The Tel Aviv-headquartered company stated its Crohn's disease treatment trial met its primary endpoint and key secondary endpoints
נאסדק נאסד"ק ניו יורק בורסה בועה

Surveillance Company Ability Looking to Raise Up to $50 Million in Shelf Offering

26.07.18|CTech
Earlier this month, the Tel Aviv-based company announced it has received a delisting determination from Nasdaq
שבתאי אדלרסברג

In Pivot, AudioCodes to Pay Out Dividends

25.07.18|Dror Reich
Revenue grew 12.3 percent to $43.5 million compared to the second quarter of last year
נאסדק נאסד"ק ניו יורק בורסה בועה

Wix.com Reports Higher Revenue and Improved Yearly Forecast

25.07.18|Asaf Shalev
The provider of website building tools also said it turned a profit in the second quarter excluding one-time items
Previous ArticlesMore Articles